Bladder Cancer News

Christopher Filson, MD, on exploring bladder cancer biomarkers - Urology Times

Christopher Filson, MD, on exploring bladder cancer biomarkers Urology Times

Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress - Yahoo Finance

Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress Yahoo Finance

A Mentor, Innovator, and Leader in Bladder Cancer - University of Rochester Medical Center

A Mentor, Innovator, and Leader in Bladder Cancer University of Rochester Medical Center

Study finds link between colorblindness and death from bladder cancer - Stanford Medicine

Study finds link between colorblindness and death from bladder cancer Stanford Medicine

Colorblindness linked to higher risk of delayed bladder cancer detection - The Brighter Side of News

Colorblindness linked to higher risk of delayed bladder cancer detection The Brighter Side of News

NHS updates bladder cancer chemotherapy guidelines - News-Medical

NHS updates bladder cancer chemotherapy guidelines News-Medical

New drug developed at UC Davis offers hope to bladder cancer patients - University of California - Davis Health

New drug developed at UC Davis offers hope to bladder cancer patients University of California - Davis Health

Karrueche Tran, Deion Sanders nearly split during his cancer battle - Buffaloes Wire

Karrueche Tran, Deion Sanders nearly split during his cancer battle Buffaloes Wire

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - The New England Journal of Medicine

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer The New England Journal of Medicine

Patient donates bell 'of hope' and gets first ring - BBC

Patient donates bell 'of hope' and gets first ring BBC

Developing Clinical Complete Response Definitions for Muscle-Invasive Bladder Cancer - ASCO Daily News

Developing Clinical Complete Response Definitions for Muscle-Invasive Bladder Cancer ASCO Daily News

Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients - Memorial Sloan Kettering Cancer Center

Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients Memorial Sloan Kettering Cancer Center

Bladder Cancer: What You Need to Know - University of Colorado Anschutz

Bladder Cancer: What You Need to Know University of Colorado Anschutz

Advances in the management of localized bladder cancers - Nature

Advances in the management of localized bladder cancers Nature

Bladder Cancer Remission Rate: What Patients Need to Know in 2025 - Oncodaily

Bladder Cancer Remission Rate: What Patients Need to Know in 2025 Oncodaily

Tracey Emin Lost Her Bladder and Got a New Lease on Life - Time Magazine

Tracey Emin Lost Her Bladder and Got a New Lease on Life Time Magazine

Despite ADC’s Withdrawal, TROP2 Targeting Still Has Potential in Bladder Cancer - Oncology News Central

Despite ADC’s Withdrawal, TROP2 Targeting Still Has Potential in Bladder Cancer Oncology News Central

Christopher Filson, MD, on the evolving role of biomarkers in microhematuria workups - Urology Times

Christopher Filson, MD, on the evolving role of biomarkers in microhematuria workups Urology Times

Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium - Yahoo Finance

Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium Yahoo Finance

USC study suggests type 1 diabetes may significantly raise bladder cancer risk - Keck School of Medicine of USC

USC study suggests type 1 diabetes may significantly raise bladder cancer risk Keck School of Medicine of USC

10 Ongoing Clinical Trials on Immunotherapy in Bladder Cancer - Oncodaily

10 Ongoing Clinical Trials on Immunotherapy in Bladder Cancer Oncodaily

Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies - Nature

Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies Nature

MRI-First Staging Hastens Treatment, Boosts Survival in Bladder Cancer - Targeted Oncology

MRI-First Staging Hastens Treatment, Boosts Survival in Bladder Cancer Targeted Oncology

What to expect if you have bladder cancer - Mayo Clinic Press

What to expect if you have bladder cancer Mayo Clinic Press

Technology originating at MIT leads to approved bladder cancer treatment - MIT News

Technology originating at MIT leads to approved bladder cancer treatment MIT News

HER2 in Bladder Cancer: A Frequent but Complex and Dynamic Biomarker - Daniele Raggi - UroToday

HER2 in Bladder Cancer: A Frequent but Complex and Dynamic Biomarker - Daniele Raggi UroToday

Outcomes of sequential therapy for advanced upper tract urothelial cancer and bladder cancer - Nature

Outcomes of sequential therapy for advanced upper tract urothelial cancer and bladder cancer Nature

New Drug-Releasing System Eliminates Bladder Cancer in Over 80 of Patients in a Phase II Trial - The ASCO Post

New Drug-Releasing System Eliminates Bladder Cancer in Over 80 of Patients in a Phase II Trial The ASCO Post

"Our goal is a solution for every bladder cancer patient" - Johnson & Johnson

"Our goal is a solution for every bladder cancer patient" Johnson & Johnson

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated - Johnson & Johnson

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated Johnson & Johnson

Groundbreaking Advances for Patients with Muscle-Invasive Bladder Cancer and More to Come - Memorial Sloan Kettering Cancer Center

Groundbreaking Advances for Patients with Muscle-Invasive Bladder Cancer and More to Come Memorial Sloan Kettering Cancer Center